-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Kura Oncology, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Kura Oncology, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$54.4M, a 40.9% decline year-over-year.
- Kura Oncology, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$198M, a 38.2% decline year-over-year.
- Kura Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$153M, a 12.4% decline from 2022.
- Kura Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$136M, a 4.12% decline from 2021.
- Kura Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$130M, a 45.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)